{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:47:09Z","timestamp":1780091229970,"version":"3.54.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41409-018-0193-6","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T11:19:52Z","timestamp":1525173592000},"page":"1390-1400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility"],"prefix":"10.1038","volume":"53","author":[{"given":"Hafiz Muhammad","family":"Aslam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adetola","family":"Kassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumaila Muhammad","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrukh K.","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"193_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1179\/102453312X13376952196539","volume":"17","author":"LH Xu","year":"2012","unstructured":"Xu L-H, Fang J-P, Xu H-G, Weng W-J. Homing and engraftment of bone marrow cells derived from different donors in a murine model of sensitization. Hematology. 2012;17:215\u201319.","journal-title":"Hematology"},{"key":"193_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.bmt.1702518","volume":"26","author":"K Besien","year":"2000","unstructured":"Van Besien K, Bartholomew A, Stock W, Peace D. Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease. Bone Marrow transplant. 2000;26:445-9.","journal-title":"Bone Marrow transplant"},{"key":"193_CR3","doi-asserted-by":"crossref","unstructured":"Oringanje C, Nemecek E, Oniyangi O. Hematopoietic stem cell transplantation for people with sickle cell disease. Cochrane Library. 2016;CD007001.","DOI":"10.1002\/14651858.CD007001.pub4"},{"key":"193_CR4","doi-asserted-by":"crossref","unstructured":"Oringanje C, Nemecek E, Oniyangi O. Hematopoietic stem cell transplantation for children with sickle cell disease. Cochrane Library. 2009;CD007001.","DOI":"10.1002\/14651858.CD007001.pub2"},{"key":"193_CR5","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","volume":"129","author":"E Gluckman","year":"2017","unstructured":"Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, et al. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood. 2017;129:1548\u201356.","journal-title":"Blood"},{"key":"193_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/2040620713483063","volume":"4","author":"S Shenoy","year":"2013","unstructured":"Shenoy S. Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions. Ther Adv Hematol. 2013;4:335\u201344.","journal-title":"Ther Adv Hematol"},{"key":"193_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1182\/asheducation-2011.1.273","volume":"2011","author":"S Shenoy","year":"2011","unstructured":"Shenoy S. Hematopoietic stem cell transplantation for sickle cell disease: current practice and emerging trends. Hematol Am Soc Hematol Educ Program. 2011;2011:273\u201379.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"193_CR8","doi-asserted-by":"crossref","unstructured":"Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Cochrane Database Syst Rev 2014;C010189.","DOI":"10.1002\/14651858.CD010189.pub2"},{"key":"193_CR9","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","volume":"120","author":"J Bolanos-Meade","year":"2012","unstructured":"Bolanos-Meade J, Fuchs EJ, Luznik L, Lanzkron SM, Gamper CJ. HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood. 2012;120:4285\u201391.","journal-title":"Blood"},{"key":"193_CR10","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","volume":"367","author":"C Anasetti","year":"2012","unstructured":"Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. New Engl J Med. 2012;367:1487\u201396.","journal-title":"New Engl J Med"},{"key":"193_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000046530","volume":"105","author":"K Rezvani","year":"2001","unstructured":"Rezvani K, Flanagan AM, Sarma U, Constantinovici N, Bain BJ. Investigation of ethnic neutropenia by assessment of bone marrow colony-forming cells. Acta Haematol. 2001;105:32\u20137.","journal-title":"Acta Haematol"},{"key":"193_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4274\/tjh.2014.0311","volume":"32","author":"H Ozdogu","year":"2015","unstructured":"Ozdogu H, Boga C. Hematopoietic stem cell transplantation in adult sickle cell disease: problems and solutions. Turk J Haematol. 2015;32:195\u2013205.","journal-title":"Turk J Haematol"},{"key":"193_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12026-009-8139-0","volume":"47","author":"L Luznik","year":"2010","unstructured":"Luznik L, Fuchs EJ. High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunol Res. 2010;47:65\u201377.","journal-title":"Immunol Res"},{"key":"193_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00277-017-2936-7","volume":"96","author":"E Knuppel","year":"2017","unstructured":"Knuppel E, Medinger M, Stehle G, Infanti L, Halter J. Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure. Ann Hematol. 2017;96:703\u20135.","journal-title":"Ann Hematol"},{"key":"193_CR15","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0031-3955(02)00026-3","volume":"49","author":"P Woodard","year":"2002","unstructured":"Woodard P, Lubin B, Walters CM. New approaches to hematopoietic cell transplantation for hematological diseases in children. Pediatr Clin North Am. 2002;49:989\u20131007.","journal-title":"Pediatr Clin North Am"},{"key":"193_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/bmt.2008.203","volume":"42","author":"RA Brodsky","year":"2008","unstructured":"Brodsky RA, Luznik L, Bolanos-Meade J, Leffell MS, Jones RJ. Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant. 2008;42:523\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"193_CR17","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1182\/blood-2009-05-218982","volume":"115","author":"P Sodani","year":"2010","unstructured":"Sodani P, Isgro A, Gaziev J, Polchi P, Paciaroni K, et al. Purified T-depleted, CD34\u2009+\u2009peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia. Blood. 2010;115:1296\u2013302.","journal-title":"Blood"},{"key":"193_CR18","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.bbmt.2010.05.003","volume":"16","author":"A Isgro","year":"2010","unstructured":"Isgro A, Marziali M, Sodani P, Gaziev J, Erer B, et al. Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia. Biol Blood Marrow Transplant. 2010;16:1557\u201366.","journal-title":"Biol Blood Marrow Transplant."},{"key":"193_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJMsa1311707","volume":"371","author":"L Gragert","year":"2014","unstructured":"Gragert L, Eapen M, Williams E, Freeman J, Spellman S, et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. New Engl J Med. 2014;371:339\u201348.","journal-title":"New Engl J Med"},{"key":"193_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/bmt.2017.49","volume":"52","author":"J Foell","year":"2017","unstructured":"Foell J, Pfirstinger B, Rehe K, Wolff D, Holler E. Haploidentical stem cell transplantation with CD3(+)-\/CD19(+)- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study. Bone Marrow Transplant. 2017;52:938\u201340.","journal-title":"Bone Marrow Transplant"},{"key":"193_CR21","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1517\/14712598.2011.592824","volume":"11","author":"X Poire","year":"2011","unstructured":"Poire X, van Besien K. Alemtuzumab in allogeneic hematopoetic stem cell transplantation. Expert Opin Biol Ther. 2011;11:1099\u2013111.","journal-title":"Expert Opin Biol Ther"},{"key":"193_CR22","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","volume":"115","author":"L Luznik","year":"2010","unstructured":"Luznik L, Bolanos-Meade J, Zahurak M, Chen AR, Smith BD, et al. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood. 2010;115:3224\u201330.","journal-title":"Blood"},{"key":"193_CR23","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ, Chen AR, Leffell MS, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008;14:641\u201350.","journal-title":"Biol Blood Marrow Transplant."},{"key":"193_CR24","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1182\/blood-2013-03-489112","volume":"122","author":"F Locatelli","year":"2013","unstructured":"Locatelli F, Kabbara N, Ruggeri A, Ghavamzadeh A, Roberts I, et al. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood. 2013;122:1072\u20138.","journal-title":"Blood"},{"key":"193_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.5966\/sctm.2012-0180","volume":"2","author":"S Shenoy","year":"2013","unstructured":"Shenoy S. Umbilical cord blood: an evolving stem cell source for sickle cell disease transplants. Stem Cells Transl Med. 2013;2:337\u201340.","journal-title":"Stem Cells Transl Med"},{"key":"193_CR26","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.bbmt.2012.01.019","volume":"18","author":"NR Kamani","year":"2012","unstructured":"Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, et al. Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant. 2012;18:1265\u201372.","journal-title":"Biol Blood Marrow Transplant."},{"key":"193_CR27","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.bbmt.2011.01.012","volume":"17","author":"A Ruggeri","year":"2011","unstructured":"Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, et al. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant. 2011;17:1375\u201382.","journal-title":"Biol Blood Marrow Transplant."},{"key":"193_CR28","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1038\/leu.2014.181","volume":"28","author":"A Dahlberg","year":"2014","unstructured":"Dahlberg A, Brashem-Stein C, Delaney C, Bernstein ID. Enhanced generation of cord blood hematopoietic stem and progenitor cells by culture with StemRegenin1 and Delta1(Ext-IgG.). Leukemia. 2014;28:2097\u2013101.","journal-title":"Leukemia"},{"key":"193_CR29","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1172\/JCI74556","volume":"124","author":"ME Horwitz","year":"2014","unstructured":"Horwitz ME, Chao NJ, Rizzieri DA, Long GD, Sullivan KM, et al. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment. J Clin Investig. 2014;124:3121\u20138.","journal-title":"J Clin Investig"},{"key":"193_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bbmt.2013.12.564","volume":"20","author":"S Kharbanda","year":"2014","unstructured":"Kharbanda S, Smith AR, Hutchinson SK, McKenna DH. Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells. Biol Blood Marrow Transplant. 2014;20:581\u20136.","journal-title":"Biol Blood Marrow Transplant."},{"key":"193_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ajh.21408","volume":"84","author":"TL Kauf","year":"2009","unstructured":"Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009;84:323\u20137.","journal-title":"Am J Hematol"},{"key":"193_CR32","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","volume":"330","author":"OS Platt","year":"1994","unstructured":"Platt OS, Brambilla DJ, Rosse WF, Milner PF. Mortality in sickle cell disease. Life expectancy and risk factors for early death. New Engl J Med. 1994;330:1639\u201344.","journal-title":"New Engl J Med"},{"key":"193_CR33","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood.V96.7.2369","volume":"96","author":"AS Wayne","year":"2000","unstructured":"Wayne AS, Schoenike SE, Pegelow CH. Financial analysis of chronic transfusion for stroke prevention in sickle cell disease. Blood. 2000;96:2369\u201372.","journal-title":"Blood"},{"key":"193_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1701291","volume":"22","author":"C Vermylen","year":"1998","unstructured":"Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant. 1998;22:1\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"193_CR35","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","volume":"110","author":"F Bernaudin","year":"2007","unstructured":"Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood. 2007;110:2749\u201356.","journal-title":"Blood"},{"key":"193_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/bmt.2011.79","volume":"47","author":"G Lucarelli","year":"2012","unstructured":"Lucarelli G, Gaziev J, Isgr\u00f2 A, Sodani P, Paciaroni K. Allogeneic cellular gene therapy in hemoglobinopathies\u2014evaluation of hematopoietic SCT in sickle cell anemia. Bone Marrow Transplant. 2012;47:227\u201330.","journal-title":"Bone Marrow Transplant"},{"key":"193_CR37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2141.2007.06592.x","volume":"137","author":"JA Panepinto","year":"2007","unstructured":"Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, et al. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol. 2007;137:479\u201385.","journal-title":"Br J Haematol"},{"key":"193_CR38","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1053\/beha.2001.0174","volume":"14","author":"G Vassiliou","year":"2001","unstructured":"Vassiliou G, Amrolia P, Roberts IA. Allogeneic transplantation for haemoglobinopathies. Best Pract Res Clin Haematol. 2001;14:807\u201322.","journal-title":"Best Pract Res Clin Haematol"},{"key":"193_CR39","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1056\/NEJMoa0904971","volume":"361","author":"MM Hsieh","year":"2009","unstructured":"Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. New Engl J Med. 2009;361:2309\u201317.","journal-title":"New Engl J Med"},{"key":"193_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/sj.bmt.1704745","volume":"35","author":"JT Horan","year":"2005","unstructured":"Horan JT, Liesveld JL, Fenton P, Blumberg N, Walters MC. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplant. 2005;35:171\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"193_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.bmt.1704795","volume":"35","author":"S Shenoy","year":"2005","unstructured":"Shenoy S, Grossman WJ, DiPersio J, Yu LC, Wilson D. A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant. 2005;35:345\u201352.","journal-title":"Bone Marrow Transplant"},{"key":"193_CR42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1083-8791(03)00192-7","volume":"9","author":"R Iannone","year":"2003","unstructured":"Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant. 2003;9:519\u201328.","journal-title":"Biol Blood Marrow Transplant."},{"key":"193_CR43","first-page":"229","volume":"6","author":"M Bhatia","year":"2015","unstructured":"Bhatia M, Sheth S. Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations. J Blood Med. 2015;6:229\u201338.","journal-title":"J Blood Med"},{"key":"193_CR44","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1182\/asheducation-2014.1.468","volume":"2014","author":"JA Talano","year":"2014","unstructured":"Talano JA, Cairo MS. Smoothing the crescent curve: sickle cell disease. Hematol Am Soc Hematol Educ Program. 2014;2014:468\u201374.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"193_CR45","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1056\/NEJMc1000134","volume":"362","author":"MC Walters","year":"2010","unstructured":"Walters MC, Sullivan KM. Stem-cell transplantation for sickle cell disease. New Engl J Med. 2010;362:955\u20136.","journal-title":"New Engl J Med"},{"key":"193_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1701291","volume":"22","author":"C Vermylen","year":"1998","unstructured":"Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant. 1998;22:1\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"193_CR47","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.hoc.2010.08.004","volume":"24","author":"J Gaziev","year":"2010","unstructured":"Gaziev J, Lucarelli G. Allogeneic cellular gene therapy for hemoglobinopathies. Hematol\/Oncol Clin North Am. 2010;24:1145\u201363.","journal-title":"Hematol\/Oncol Clin North Am"},{"key":"193_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0268-960X(03)00006-7","volume":"17","author":"C Vermylen","year":"2003","unstructured":"Vermylen C. Hematopoietic stem cell transplantation in sickle cell disease. Blood Rev. 2003;17:163\u20136.","journal-title":"Blood Rev"},{"key":"193_CR49","doi-asserted-by":"publisher","first-page":"a011825","DOI":"10.1101\/cshperspect.a011825","volume":"2","author":"G Lucarelli","year":"2012","unstructured":"Lucarelli G, Isgro A, Sodani P, Gaziev J. Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. Cold Spring Harb Perspect Med. 2012;2:a011825.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"193_CR50","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2174\/156652408786241393","volume":"8","author":"JG Michlitsch","year":"2008","unstructured":"Michlitsch JG, Walters MC. Recent advances in bone marrow transplantation in hemoglobinopathies. Curr Mol Med. 2008;8:675\u201389.","journal-title":"Curr Mol Med"},{"key":"193_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.anpedi.2012.12.002","volume":"79","author":"R Hladun","year":"2013","unstructured":"Hladun R, Elorza I, Olive T, Dapena JL, Llort A, Sanchez de Toledo J, Diaz, de Heredia C. Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease. An De Pediatr (Barc, Spain: 2003). 2013;79:75\u201382.","journal-title":"An De Pediatr (Barc, Spain: 2003)"},{"key":"193_CR52","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bbmt.2014.12.007","volume":"21","author":"M Bhatia","year":"2015","unstructured":"Bhatia M, Kolva E, Cimini L, Jin Z, Satwani P, et al. Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease. Biol Blood Marrow Transplant. 2015;21:666\u201372.","journal-title":"Biol Blood Marrow Transplant."},{"key":"193_CR53","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.bbmt.2013.02.010","volume":"19","author":"MH Dallas","year":"2013","unstructured":"Dallas MH, Triplett B, Shook DR, Hartford C, Srinivasan A. Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant. 2013;19:820\u201330.","journal-title":"Biol Blood Marrow Transplant."},{"key":"193_CR54","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.bbmt.2012.11.007","volume":"19","author":"D Choudhary","year":"2013","unstructured":"Choudhary D, Sharma SK, Gupta N, Kharya G, Pavecha P. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India. Biol Blood Marrow Transplant. 2013;19:492\u20135.","journal-title":"Biol Blood Marrow Transplant."},{"key":"193_CR55","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bjh.13352","volume":"169","author":"L Strocchio","year":"2015","unstructured":"Strocchio L, Zecca M, Comoli P, Mina T, Giorgiani G. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease. Br J Haematol. 2015;169:726\u201336.","journal-title":"Br J Haematol"},{"key":"193_CR56","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1182\/asheducation-2013.1.370","volume":"2013","author":"E Gluckman","year":"2013","unstructured":"Gluckman E. Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease. Hematol Am Soc Hematol Educ Program. 2013;2013:370\u20136.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"193_CR57","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMc1704009","volume":"376","author":"M Badat","year":"2017","unstructured":"Badat M, Davies J. Gene therapy in a patient with sickle cell disease. New Engl J Med. 2017;376:2093\u20134.","journal-title":"New Engl J Med"},{"key":"193_CR58","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1182\/blood-2002-07-2090","volume":"101","author":"F Locatelli","year":"2003","unstructured":"Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003;101:2137\u201343.","journal-title":"Blood"},{"key":"193_CR59","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood.V85.4.879.bloodjournal854879","volume":"85","author":"MC Walters","year":"1995","unstructured":"Walters MC, Sullivan KM, Bernaudin F, Souillet G, Vannier JP, Johnson FL, et al. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood. 1995;85:879\u201384.","journal-title":"Blood"},{"key":"193_CR60","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1196\/annals.1345.024","volume":"1054","author":"J Gaziev","year":"2005","unstructured":"Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G. Bone marrow transplantation in adults with thalassemia: treatment and long-term follow-up. Ann NY Acad Sci. 2005;1054:196\u2013205.","journal-title":"Ann NY Acad Sci"},{"key":"193_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1056\/NEJM200101043440119","volume":"344","author":"L Krishnamurti","year":"2001","unstructured":"Krishnamurti L, Blazar BR, Wagner JE. Bone marrow transplantation without myeloablation for sickle cell disease. New Engl J Med. 2001;344:68.","journal-title":"New Engl J Med"},{"key":"193_CR62","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","volume":"110","author":"F Bernaudin","year":"2007","unstructured":"Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood. 2007;110:2749\u201356.","journal-title":"Blood"},{"key":"193_CR63","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1056\/NEJM200101043440119","volume":"344","author":"L Krishnamurti","year":"2001","unstructured":"Krishnamurti L, Blazar BR, Wagner JE: Bone marrow transplantation without myeloablation for sickle cell disease. The New England journal of medicine 2001;344:68.","journal-title":"The New England journal of medicine"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0193-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0193-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0193-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:12:04Z","timestamp":1684617124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0193-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["193"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0193-6","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"18 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}